BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vatech Partners with Tygerberg Hospital to Enhance Dental Healthcare in South Africa

Vatech, a global leader in the dental imaging market, is launching a project to improve dental healthcare in South Africa. Vatech announced that it ha...

May 24, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

May 23, 2024 | News

Lunit Completes Acquisition of Volpara Health Technologies, Enhancing AI-Driven Cancer Diagnostics

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of i...

May 23, 2024 | News

GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'

GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this appr...

May 21, 2024 | News

SN Bioscience’s SNB-101 Receives FDA Fast Track Designation for Breakthrough Small Cell Lung Cancer Treatment

SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (...

May 13, 2024 | News

Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...

May 08, 2024 | News

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | News

HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment

HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...

May 06, 2024 | News

AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA

AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...

April 30, 2024 | News

Onconic Therapeutics Gains South Korean Approval for Innovative GERD Treatment JAQBO

Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...

April 26, 2024 | News

Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...

April 26, 2024 | News

Samsung Biologics Reports Robust Growth in First Quarter of 2024, Revenue Surges by 31.3%

Recorded Q1'24 consolidated revenue of KRW 946.9 billion Recorded Q1'24 consolidated operating profit of KRW 221.3 billion Sustained growth d...

April 25, 2024 | News

Hanmi Pharmaceutical Partners with MSD to Advance Immuno-Oncology Drug BH3120 in New Clinical Trial

Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...

April 24, 2024 | News

OSR Holdings and SillaJen Forge Strategic Partnership to Enhance Immuno-Oncology Drug Development

OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech ...

April 23, 2024 | News

Stay Connected